RxDoctor Payments Data

Joseph Lee

Nephrology · Riverside, CANPI 1477599579

Payments from drug & device makers

$118,286in general payments, 2019–2025

Across 87 payments — averaging $1359.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$97K
  • AstraZeneca$14K
  • AbbVie$5K
  • Novo Nordisk AS$750
  • Gilead$455
  • Amgen$427
  • plus $442 from 7 others
$425in research payments, 2019–2025

Across 1 payment — averaging $425.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$425

What the payments were for

  • Speaking & faculty fees$8,55075%
  • Travel & lodging$8638%
  • Food & beverage$2,04918%

General payments by program year

19
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$118,286 in reported general payments places this provider in the 90th percentile of 1,341 nephrology providers in California.

See all nephrology providers in California

Other nephrology in Riverside

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →